Equities Analysts Set Expectations for TriMas Q1 Earnings

TriMas Co. (NASDAQ:TRS) – Analysts at BWS Financial increased their Q1 2025 earnings estimates for shares of TriMas in a research report issued to clients and investors on Thursday, January 23rd. BWS Financial analyst H. Khorsand now anticipates that the industrial products company will earn $0.44 per share for the quarter, up from their previous forecast of $0.43. BWS Financial currently has a “Buy” rating and a $40.00 target price on the stock. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. BWS Financial also issued estimates for TriMas’ Q2 2025 earnings at $0.54 EPS, Q3 2025 earnings at $0.61 EPS, Q4 2025 earnings at $0.46 EPS and FY2025 earnings at $2.04 EPS.

TriMas (NASDAQ:TRS) last announced its earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.14). The business had revenue of $229.36 million for the quarter, compared to analysts’ expectations of $239.33 million. TriMas had a net margin of 2.93% and a return on equity of 9.21%. The company’s quarterly revenue was down 2.5% on a year-over-year basis. During the same quarter last year, the business earned $0.57 EPS.

Separately, StockNews.com upgraded shares of TriMas from a “sell” rating to a “hold” rating in a research report on Wednesday, November 13th.

TriMas Stock Performance

NASDAQ TRS opened at $24.67 on Monday. TriMas has a 1-year low of $22.24 and a 1-year high of $28.51. The company has a market cap of $1.00 billion, a PE ratio of 38.55 and a beta of 0.67. The stock’s 50 day simple moving average is $25.03 and its 200-day simple moving average is $25.44. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44.

Institutional Trading of TriMas

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Aristides Capital LLC purchased a new position in shares of TriMas during the 2nd quarter worth approximately $245,000. Intech Investment Management LLC purchased a new stake in TriMas during the third quarter worth approximately $269,000. Paloma Partners Management Co purchased a new stake in shares of TriMas during the 3rd quarter worth approximately $293,000. XTX Topco Ltd acquired a new position in TriMas in the third quarter valued at $371,000. Finally, Algert Global LLC boosted its position in shares of TriMas by 4.2% in the 2nd quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock valued at $403,000 after purchasing an additional 639 shares during the period. Institutional investors and hedge funds own 99.42% of the company’s stock.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.